Wells Health Group
  • About Us
  • Health Policy
    • CPT/HCPCS Coding
    • FDA - Emergency Use Authorization (EUA)
    • Medicare 101
  • Government Relations
  • M&A Advisors
  • Leadership
  • Community
  • Contact
Health Policy = Strategy Analytics + Reimbursement Pathways
  • WHG’s innovative approach to health policy consulting is based on a core set of essential strategy analytics and focused reimbursement pathways based on real life healthcare industry experiences.
  • We provide clients a systematic and targeted engagement by working sequentially through interconnected groups of analytics to verify solid sustainable health policy strategies and reimbursement pathway tactics.
  • WHG specializes in healthcare consulting for pharmaceutical, medical device, specialty pharmacy, medical management, physician services, M&A advisors and innovators to help maximize stakeholder value.
Picture

Health Policy Challenges
  • Government agency and reimbursement processes are not always intuitive and can lead to uncertainties and misconceptions.
  • FDA approval and FDA clearance allows for commercialization. It does not mean that a product is covered or eligible for reimbursement by Medicare, Medicaid, or commercial insurance.
  • FDA approved indications for use and FDA product coding can result in potential downstream consequences.  These FDA controlled regulations affect site of care utilization, benefit category determination, coverage criteria and payment.
  • Establishing a new HCPCS/CPT code does not equate to CMS coverage or payment, as these reimbursement steps are separate CMS processes.
  • The cost of innovation is not an inevitable part of payment calculation processes.​

Picture
Core Set of Essential Strategy Analytics

Comprehensive Medicare, Medicaid and commercial insurance reimbursement pathway analysis
  • Guidance through all 7-reimbursement steps - from diagnosis, treatment pan, site of care, and benefit category to coding, coverage and payment. Too often, clients start in the middle with coding and not at the beginning of the pathway with the diagnosis.
  • Encounter data analysis, metrics and trends - key drivers of HHS and CMS decision-making trends
  • CPT-RVU build up analysis - key drivers of the annual Medicare physicians fee schedule (MPFS) rule making process and trends
  • Identify hurdles and opportunities in the six step reimbursement pathway
​Categorize the foundation of the hurdles or opportunities
  • Policy clarification
  • Benefit manual revision
  • Coding modification
  • Coverage expansion
  • Payment revaluation
Identify the current political and policy landscape
  • Who can influence the change?
  • What is the appetite for change?
Strategy analytics is the foundation for developing reimbursement pathways

Picture
Focused Reimbursement Pathways

We identify the foundation of reimbursement hurdles or opportunities and prioritize executable milestones to maximize reimbursement
  • Policy Clarification – Less formal instrument to expanded coverage criteria
  • Benefit Manual Revision – Subject to legislative language interpretation and clarification
  • Coding Modification – New code, descriptor modification, code verification
  • Coverage Expansion – More formal evidence based route to expanded coverage criteria in the form of an NCD, LCD and policy article
  • Payment Revaluation – Update pre-set data points, multi-layered variables and complicated formulas utilized to calculate fee schedules and prospective payment rates​​
We determine the pathway tactics once the actionable reimbursement strategies are defined and prioritized
  • Determine HHS and CMS policy jurisdiction
  • Outline HHS and CMS decision-making processes
  • Identify HHS and CMS key decision-makers and influencers
  • Determine Capitol Hill policy jurisdiction, appropriations and oversight responsibilities
  • Identify Capitol Hill key decision-makers and influencer

Health Policy Trends - Are You Prepared?
  • ACA?
  • Expanded Medicaid
  • Legislated Alternative Payment Models (APMs)
  • Bundled payments
  • Consolidating health systems
  • Consolidating payers
  • Local Coverage Determinations (LCD) revisions
  • National Coverage Determinations (NCD) revisions
  • Price erosion
  • Quality measures and standards
  • Value-based pricing
  • Tighter coverage criteria
  • Prior authorization
Wells Health Group
565 Pennsylvania Ave. NW Suite #614     
Washington, D.C. 20001
info@wellshealthgroup.com
Office:  202.629.4366
Contact us to discuss how we can help
Proudly powered by Weebly